ampelopsin has been researched along with Skin Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YM; Peng, Y; Sun, HY; Yue, JQ; Zhong, ZJ; Zhou, DZ | 1 |
1 other study(ies) available for ampelopsin and Skin Neoplasms
| Article | Year |
|---|---|
Dihydromyricetin induces apoptosis and cytoprotective autophagy through ROS-NF-κB signalling in human melanoma cells.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cytoprotection; Drug Screening Assays, Antitumor; Flavonols; Humans; Melanoma; NF-kappa B; Reactive Oxygen Species; Signal Transduction; Skin Neoplasms | 2017 |